FDA Advisers Back Pfizer/BioNTech COVID-19 Vaccine for Children

Published on October 26, 2021

An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.

Read Full Article (External Site)